BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
19 results:

  • 1. Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study.
    Majaliwa E; Smith ER; Cotache-Condor C; Rice H; Gwanika Y; Canick J; Chao N; Schroeder K; Rice HE; Staton C; Mmbaga BT
    JCO Glob Oncol; 2023 Jun; 9():e2200263. PubMed ID: 37384861
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pax-5 Protein Expression Is Regulated by Transcriptional 3'UTR Editing.
    Beauregard AP; Hannay B; Gharib E; Crapoulet N; Finn N; Guerrette R; Ouellet A; Robichaud GA
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011638
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification and staging of B-Cell Acute Lymphoblastic leukemia Using Quantitative Phase Imaging and Machine Learning.
    Ayyappan V; Chang A; Zhang C; Paidi SK; Bordett R; Liang T; Barman I; Pandey R
    ACS Sens; 2020 Oct; 5(10):3281-3289. PubMed ID: 33092347
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
    Staber PB; Herling M; Bellido M; Jacobsen ED; Davids MS; Kadia TM; Shustov A; Tournilhac O; Bachy E; Zaja F; Porkka K; Hoermann G; Simonitsch-Klupp I; Haferlach C; Kubicek S; Mayerhoefer ME; Hopfinger G; Jaeger U; Dearden C
    Blood; 2019 Oct; 134(14):1132-1143. PubMed ID: 31292114
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.
    Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies F; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan G
    Leukemia; 2019 Jan; 33(1):159-170. PubMed ID: 29967379
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Musculoskeletal Imaging Findings of Hematologic Malignancies.
    Navarro SM; Matcuk GR; Patel DB; Skalski M; White EA; Tomasian A; Schein AJ
    Radiographics; 2017; 37(3):881-900. PubMed ID: 28388273
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients.
    Piszcz J; Armitage EG; Ferrarini A; Rupérez FJ; Kulczynska A; Bolkun L; Kloczko J; Kretowski A; Urbanowicz A; Ciborowski M; Barbas C
    Oncotarget; 2016 Apr; 7(16):22324-38. PubMed ID: 26988915
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of cellular senescence signature on ageing research.
    Sikora E; Arendt T; Bennett M; Narita M
    Ageing Res Rev; 2011 Jan; 10(1):146-52. PubMed ID: 20946972
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective.
    Kumar N; Varma N; Varma S; Malhotra P
    Anal Quant Cytol Histol; 2009 Oct; 31(5):296-303. PubMed ID: 20701097
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Myelodysplasic syndromes: a comprehensive review.
    Catenacci DV; Schiller GJ
    Blood Rev; 2005 Nov; 19(6):301-19. PubMed ID: 15885860
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
    Lossos IS; Breuer R; Intrator O; Lossos A
    Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis and validation of prognostic factors for CML. German CML Study Group.
    Hasford J; Ansari H; Pfirrmann M; Hehlmann R
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S49-54. PubMed ID: 8769702
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Hematological neoplasm--how to treat low-grade lymphomas].
    Hirano M
    Rinsho Ketsueki; 1995 May; 36(5):465-70. PubMed ID: 7783352
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
    Cheson BD; Bennett JM; Rai KR; Grever MR; Kay NE; Schiffer CA; Oken MM; Keating MJ; Boldt DH; Kempin SJ
    Am J Hematol; 1988 Nov; 29(3):152-63. PubMed ID: 3189311
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multivariate analysis of prognostic factors in chronic lymphocytic leukemia.
    Prokocimer M; Modan M; Lusky A; Hershko C
    Isr J Med Sci; 1985 Jun; 21(6):490-8. PubMed ID: 4019142
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.